Assertio Therapeutics Inc.

(ASRT) Trade

By |

Profile

Assertio Therapeutics Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid filled capsules for relief of mild to moderate pain.

Contact Information

Website: www.assertiotx.com
Email: investors@assertiotx.com
Main Phone: +1 224 419-7106
Address: 100 South Saunders Road
Address 2: Suite 300
State: IL
City / Town: Lake Forest
Country: USA
Postal Code: 60045

Issuer Information

Exchange: NGS
CEO: Arthur J. Higgins
Employees: 116
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Assertio Therapeutics Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid filled capsules for relief of mild to moderate pain.

Contact Information

Website: www.assertiotx.com
Email: investors@assertiotx.com
Main Phone: +1 224 419-7106
Address: 100 South Saunders Road
Address 2: Suite 300
State: IL
City / Town: Lake Forest
Country: USA
Postal Code: 60045

Issuer Information

Exchange: NGS
CEO: Arthur J. Higgins
Employees: 116
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 0.77 $ -0.0003 (-0.04%)
Last Price 0.77 Change $ -0.0003 Change % -0.04 Tick N/A
Bid 0.66 Bid Size 1,600.00 Ask 1.03 Ask Size 100.00
Open 0.78 High 0.81 Low 0.73 Prev Close 0.77
Last Trade Volume 1.2 mi 52 Wk Hi 5.76 52 Wk Low 0.70
Market Cap 62 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 80,681,036.00 EPS (TTM) -0.74 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 10
Number of Buys 0 4
Number of Sells 0 6
Net Activity 0 11458
Last 10 Buys Shares
Arthur J. Higgins 1,000
Arthur J. Higgins 1,000
James A. Schoeneck 1,000
Karen A. Dawes 1,000
Peter D. Staple 1,000
Peter D. Staple 1,000
Peter D. Staple 1,000
Peter D. Staple 1,000
Peter D. Staple 1,000
Peter D. Staple 1,000
Last 10 Sell Shares
Matthew M. Gosling 1,000
Matthew M. Gosling 1,000
Thadd M. Vargas 1,000
Thadd M. Vargas 1,000
Thadd M. Vargas 1,000
Matthew M. Gosling 1,000
Thadd M. Vargas 1,000
August J. Moretti 1,000
Thadd M. Vargas 1,000
August J. Moretti 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 10
Low Target Price Estimate 6 6 6 6
Mean Target Price Estimate 8.43 8.43 8.43 8.43
Standard Deviation 1.51 1.51 1.51 1.51
Date of Most Recent Estimate 07/24/18 07/24/18 07/24/18 08/08/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 3 2 2
Moderate Buy 0 0 0 0
Hold 2 3 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2 2 2.33 2.33